coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [Andexxa]

RxCUI: 2108130
RxNorm name: coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [Andexxa]
Display name: coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [Andexxa]
Full name: coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [Andexxa]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125586	Andexxa	Coagulation Factor Xa (Recombinant), Inactivated-zhzo	351(a)	Disc	2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ANDEXXA	ANDEXANET ALFA	AstraZeneca Pharmaceuticals LP	2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c	2025-05-23	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2108130

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c	ANDEXXA 200 MG Injection [PSN] · coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [Andexxa] [SBD] · Andexxa 200 MG Injection [SY]	3	7	These highlights do not include all the information needed to use ANDEXXA safely and effectively. See Full Prescribing Information for ANDEXXA. ANDEXXA ® (coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 2018	20250523